BR9510060A - Receptor - Google Patents
ReceptorInfo
- Publication number
- BR9510060A BR9510060A BR9510060A BR9510060A BR9510060A BR 9510060 A BR9510060 A BR 9510060A BR 9510060 A BR9510060 A BR 9510060A BR 9510060 A BR9510060 A BR 9510060A BR 9510060 A BR9510060 A BR 9510060A
- Authority
- BR
- Brazil
- Prior art keywords
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9425502.3A GB9425502D0 (en) | 1994-12-17 | 1994-12-17 | Novel receptor |
PCT/EP1995/004998 WO1996018650A1 (en) | 1994-12-17 | 1995-12-11 | Novel receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9510060A true BR9510060A (pt) | 1998-06-02 |
Family
ID=10766105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9510060A BR9510060A (pt) | 1994-12-17 | 1995-12-11 | Receptor |
Country Status (15)
Country | Link |
---|---|
US (1) | US5985334A (pt) |
EP (1) | EP0807122A1 (pt) |
JP (1) | JPH10511083A (pt) |
CN (1) | CN1175262A (pt) |
AU (1) | AU710150B2 (pt) |
BR (1) | BR9510060A (pt) |
CA (1) | CA2207921A1 (pt) |
CZ (1) | CZ187697A3 (pt) |
FI (1) | FI972558A0 (pt) |
GB (1) | GB9425502D0 (pt) |
HU (1) | HUT77077A (pt) |
NO (1) | NO972771L (pt) |
NZ (1) | NZ298059A (pt) |
PL (1) | PL320747A1 (pt) |
WO (1) | WO1996018650A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245893B1 (en) * | 1994-12-17 | 2001-06-12 | Smithkline Beecham P.L.C. | Receptor that binds anti-convulsant compounds |
CA3168730A1 (en) * | 2020-03-10 | 2021-09-16 | Heather BUCKLEY | Light-activated pathogen-killing molecules and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
GB9225860D0 (en) * | 1992-12-11 | 1993-02-03 | Smithkline Beecham Plc | Novel treatment |
EP0665887B1 (en) * | 1993-08-20 | 1998-10-14 | Smithkline Beecham Plc | Human 5-ht 2? receptor |
-
1994
- 1994-12-17 GB GBGB9425502.3A patent/GB9425502D0/en active Pending
-
1995
- 1995-12-11 HU HU9702146A patent/HUT77077A/hu unknown
- 1995-12-11 CZ CZ971876A patent/CZ187697A3/cs unknown
- 1995-12-11 CA CA002207921A patent/CA2207921A1/en not_active Abandoned
- 1995-12-11 WO PCT/EP1995/004998 patent/WO1996018650A1/en not_active Application Discontinuation
- 1995-12-11 AU AU43458/96A patent/AU710150B2/en not_active Ceased
- 1995-12-11 CN CN95197647A patent/CN1175262A/zh active Pending
- 1995-12-11 NZ NZ298059A patent/NZ298059A/xx unknown
- 1995-12-11 EP EP95942175A patent/EP0807122A1/en not_active Withdrawn
- 1995-12-11 US US08/849,860 patent/US5985334A/en not_active Expired - Fee Related
- 1995-12-11 JP JP8518283A patent/JPH10511083A/ja active Pending
- 1995-12-11 BR BR9510060A patent/BR9510060A/pt not_active Application Discontinuation
- 1995-12-11 PL PL95320747A patent/PL320747A1/xx unknown
-
1997
- 1997-06-16 FI FI972558A patent/FI972558A0/fi unknown
- 1997-06-16 NO NO972771A patent/NO972771L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO972771L (no) | 1997-08-15 |
FI972558A (fi) | 1997-06-16 |
CA2207921A1 (en) | 1996-06-20 |
AU710150B2 (en) | 1999-09-16 |
US5985334A (en) | 1999-11-16 |
PL320747A1 (en) | 1997-10-27 |
JPH10511083A (ja) | 1998-10-27 |
AU4345896A (en) | 1996-07-03 |
HUT77077A (hu) | 1998-03-02 |
NZ298059A (en) | 2000-03-27 |
GB9425502D0 (en) | 1995-02-15 |
CN1175262A (zh) | 1998-03-04 |
EP0807122A1 (en) | 1997-11-19 |
CZ187697A3 (en) | 1997-10-15 |
MX9704560A (es) | 1997-10-31 |
NO972771D0 (no) | 1997-06-16 |
WO1996018650A1 (en) | 1996-06-20 |
FI972558A0 (fi) | 1997-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI955927A0 (fi) | Substituoidut 1H-imidatsolit | |
DE69528341T2 (de) | Spritzenendstückkappe | |
DE69527293T2 (de) | Kryogenarbeiten | |
ATA166795A (de) | Bis-resorcinyltriazine | |
FI950700A (fi) | Doksisykliinianalogeja | |
ATA147195A (de) | Alkoxyphenyl-substituierte bisbenzoylphosphinoxide | |
ATA163695A (de) | 2-hydroxyphenyltriazine | |
DE69534718D1 (de) | Substituierte 9-alkyladenine | |
NO970740D0 (no) | Glutamat reseptor | |
DE69535345D1 (de) | Fixiergerät | |
DE69523138T2 (de) | Netzfilter | |
ATA108995A (de) | Differenzdruckakkumulator | |
BR9509559A (pt) | Azolilulsolfonilfeniluracilas substituídas | |
DE69431672D1 (de) | Adrenergischer rezeptor | |
BR9510060A (pt) | Receptor | |
DE69524478T2 (de) | Kodeumsetzungssystem | |
ATA11894A (de) | Stauförderbahn | |
DE59510274D1 (de) | Substituierte biphenyloxazoline | |
KR960009736U (ko) | 장화 | |
FI1511U1 (fi) | Luftfoerdelningsslang | |
FI1629U1 (fi) | Potatislaoda | |
FI1738U1 (fi) | Moessa | |
FI1492U1 (fi) | Bogserbar planeringsanordning | |
ATE197372T1 (de) | Vorteig | |
FIU940099U0 (fi) | Bandformigt foerpackningsmaterial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |